Books+ Search Results
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports
Title
The Oxford/AstraZeneca COVID-19 vaccine trial [electronic resource] : adverse patient event reports / an interview with Saad Shakir.
Published
London : Henry Stewart Talks, 2020.
Physical Description
1 online resource (1 streaming audio file (14 min.)).
Local Notes
Access is available to the Yale community.
Notes
Audio interview.
Title from title frames.
Access and use
Access restricted by licensing agreement.
Format
Audio / Online
Language
English
Added to Catalog
December 21, 2020
Series
Research and clinical interviews,
Contents
Contents: Mode of action of the Oxford/AstraZeneca RNA vaccine
Two potential adverse events reported in patients enrolled in the vaccine's phase 3 trial
Steps undertaken to determine possible causality between the adverse events and the vaccine
Current status of the trial
Please note that since the recording of this interview it was determined that "The serious adverse events observed during the trial in these study groups were judged to be unrelated to the study vaccines and occurred at frequencies expected for these conditions in the general population. None of the participants included in this report had any suspected unexpected serious adverse reactions." (Ramasamy et al., The Lancet, November 18, 2020, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32466-1/fulltext)..
Publisher's number
8203 Henry Stewart Talks
Subjects
Subjects (Medical)
Clinical Trials as Topic.
COVID-19 Vaccines.
COVID-19 - prevention & control.
Research Design.
severe acute respiratory syndrome coronavirus 2.
Bookmark As
Citation
